Clinical Pharmacokinetics of the Androgen Receptor Inhibitor Darolutamide in Healthy Subjects and Patients with Hepatic or Renal Impairment
media
posted on 2021-12-06, 10:42 authored by Adis journals on behalf of, Christian Zurth, Pirjo Nykänen, Gary Wilkonson, Päivi Taavitsainen, Annamari Vuorela, Funan Huang, Susanne Reschke, Mikko Koskinen<p>The above audio feature represents the opinions of the authors. For a full list of
declarations, including funding and author disclosure statements, please see
the full text online (see “read the peer-reviewed publication” opposite).© The authors, CC-BY-NC 2021.<br></p><p><br></p>
